N. Susumu — Endo Lab

article 2005

Efficient screening for ovarian cancers using a combination of tumor markers CA602 and CA546

International journal of gynecological cancer : official journal of the International Gynecological Cancer Society ·doi:10.1111/j.1048-891x.2005.15004.x

A new efficient screening for ovarian cancer based on a combination of two tumor markers, CA602 and CA546, is reported. These two tumor markers can be detected by a combination immunoenzymometric assay of these two antigens. This combinatio…

article 2005

Efficient screening for ovarian cancers using a combination of tumor markers CA602 and CA546

·doi:10.1136/ijgc-00009577-200501000-00007

article 2001

[The biological property of ovarian cancers is affected by endometriosis--with special reference to ovarian clear cell adenocarcinoma].

Nihon rinsho. Japanese journal of clinical medicine

article 1999

Prognosis of Japanese Patients with Ovarian Clear Cell Carcinoma Associated with Pelvic Endometriosis: Clinicopathologic Evaluation

Gynecologic Oncology ·doi:10.1006/gyno.1998.5284

ObjectiveOvarian clear cell carcinoma is commonly associated with pelvic endometriosis. We retrospectively evaluated clinicopathological data on the association between ovarian clear cell carcinoma and pelvic endometriosis.MethodsBetween 19…

article 1993

[Preclinical and clinical studies on a tumor marker, galactosyltransferase associated with tumor (GAT), in ovarian cancer (second report)--clinical significance of GAT and comparison with other tumor markers].

Gan to kagaku ryoho. Cancer & chemotherapy

Galactosyltransferase Associated with Tumor (GAT) was clinically studied in cases of ovarian cancer. When two cut-off levels of GAT were compared, the cut-off level of 16 U/ml (which corresponds to mean + 2SD among healthy females) was foun…